Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Oct 16, 2017

Mylan Invalidates Allergan's Patents on Restasis®

Oct 05, 2017

Mylan, in Partnership with Synthon, Receives Marketing Authorization Approval in Europe for First Generic for Copaxone® 40 mg/mL

Oct 05, 2017

Mylan Launches First AP-rated Generic Avelox® Injection

Oct 04, 2017

Mylan Confirms U.S. Launch of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and Generic for Copaxone® 20 mg/mL Once-Daily

Oct 04, 2017

Mylan Provides Support for U.S. Disaster-Relief Efforts

Oct 03, 2017

Mylan Announces U.S. FDA Approval of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day Exclusivity

Oct 02, 2017

Mylan Launches Generic Cancidas® for Injection

Sep 29, 2017

Mylan Launches Generic Gleevec® Tablets

Sep 14, 2017

Mylan Expands Women's Healthcare Portfolio with Launch of Generic Minastrin® 24 FE Tablets

Sep 13, 2017

Mylan Names Dennis Zeleny as Chief Human Relations Officer

Pagination

First page
Previous page
…
Page 15
Page 16
Page 17
Page 18
Current page 19
Page 20
Page 21
Page 22
Page 23
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.